2 news items
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
ABBV
CYTO
ONCY
24 May 24
clinical-stage company specializing in immunotherapy for oncology, presented two abstracts at the 2024 American Society of Clinical Oncology (ASCO
Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection
NVDA
RENB
7 May 24
of people affected, cancer treatments have largely produced unsatisfactory results to curb the rise in cases. According to the American Cancer Society
- Prev
- 1
- Next